Law office of Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of AMCOL International
Corporation ("AMCOL" or the "Company") (NYSE: ACO) relating to the
acquisition by Imerys S.A. ("Imerys").
Click here to learn more about the investigation http://brodsky-smith.com/722-aco-amcol--international-corporation.html,
or call: 877-534-2590. There is no cost or obligation to you.
Under the terms of the transaction, AMCOL shareholders will receive only
$41.00 in cash for each share of AMCOL stock they own. The investigation
concerns posible breaches of fiduciary duty and other violations of
state law by the Board of Directors of AMCOL for not acting in the
Company's shareholders' best interests in connection with the sale
process. The transaction may undervalue the Company as it appears to be
below the premium paid in comparable transactions and an analyst has set
a $43.00 per share price target on AMCOL stock.
If you own shares of AMCOL common stock and wish to discuss the legal
ramifications of the proposed transaction, or have any questions, you
may e-mail or call the law office of Brodsky & Smith, LLC who will,
without obligation or cost to you, attempt to answer your questions. You
may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at
Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004,
by e-mail at email@example.com,
by visiting http://brodsky-smith.com/722-aco-amcol--international-corporation.html,
calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive expertise
representing shareholders throughout the nation in securities and case
action lawsuits. The attorneys at Brodsky & Smith have been appointed by
numerous courts throughout the country to serve as lead counsel in class
actions and successfully recovered millions of dollars for our clients
and shareholders. Attorney advertising. Prior results do not guarantee a
[ Back To NFVZone's Homepage ]